Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Background Bacillus Calmette-Guerin (BCG) remains the only licensed vaccine for use against tuberculosis (TB), however, it is poorly efficacious against pulmonary TB in adults. The poor efficacy has been attributed in part to coinfections with many other unrelated pathogens that overlap geographical...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Department of Clinical Laboratory Sciences
2022
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|